Rx&D Welcomes its Newest Member: KalGene Pharmaceuticals Inc.
"We look forward to working together to grow Canada's life sciences sector to produce better health outcomes and strengthen our knowledge economy."
OTTAWA, Canada's Research-Based Pharmaceutical Companies (Rx&D) President Russell Williams is pleased to announce today the addition of KalGene Pharmaceuticals Inc. as a new biopharmaceutical member to the association, representing the innovative pharmaceutical industry in Canada.
KalGene Pharmaceuticals Inc. is a privately-held Canadian company focused on the development of oncology therapeutics and companion diagnostics with facilities located in Ontario and British Columbia.
Read Full Article...
Welcome to CFP’s Comment Section!
The Comment section of online publications is the new front in the ongoing Cancel Culture Battle.
Big Tech and Big Media are gunning for the Conservative Voice—through their Comment Sections.
Canada Free Press wishes to stay in the fight, and we want our fans, followers, commenters there with us.
We ask only that commenters keep it civil, keep it clean.
Thank You for your patience and for staying aboard the CFP ‘Mother Ship’.
READ OUR Commenting Policy